Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001214659-19-004243
Filing Date
2019-06-17
Accepted
2019-06-17 16:46:55
Documents
1
Period of Report
2019-06-13

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT marketforms-45219.html 4  
1 PRIMARY DOCUMENT marketforms-45219.xml 4 11556
  Complete submission text file 0001214659-19-004243.txt   12986
Mailing Address 201 MAIN STREET SUITE 1900 FORT WORTH TX 76102
Business Address
BRATTON DOUGLAS K (Reporting) CIK: 0001281933 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38599 | Film No.: 19901851

Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address 30 TECHNOLOGY DRIVE WARREN NJ 07059 908-941-1900
Aquestive Therapeutics, Inc. (Issuer) CIK: 0001398733 (see all company filings)

EIN.: 208623253 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations